Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in Treatment-Naive Diabetic Macular Edema (DANTE)
NCT04448496Phase 4Unknown
- Sponsor
- Yeungnam University College of Medicine
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Yeungnam University College of Medicine. Status: unknown.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04448496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448496.